Summa Health System - Barberton Campus — Barberton, Ohio

Summa Health System - Barberton Campus is a clinical research site located in Barberton, Ohio, United States 44203.

Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.

Summa Health System - Barberton Campus has participated in 50 clinical trials with 28 currently active.

Therapeutic areas: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.

Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Barberton

Browse all research sites in Ohio · View every site in Barberton

Sponsor Feasibility Report

Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Summa Health System - Barberton Campus?

Summa Health System - Barberton Campus has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Summa Health System - Barberton Campus conducted?

Summa Health System - Barberton Campus has 50 clinical trials on record, with 28 currently active. Their work covers Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.

Is Summa Health System - Barberton Campus accredited by Crixeo Clinical Trials?

Summa Health System - Barberton Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Summa Health System - Barberton Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.